|
DSpace at RU >
University Library >
Academic bibliography >
|
| Title: | EUCAST technical note on anidulafungin |
| Author(s): | Arendrup, M.C.
Rodriguez-Tudela, J.L.
Lass-Florl, C.
Cuenca-Estrella, M.
Donnelly, J.P. (107876701)
Hope, W. |
| Publication year: | 2011 |
| Document type: | Article / Letter to editor |
| Journal: | Clinical Microbiology and Infection |
| ISSN: | 1198-743X |
| Volume: | vol. 17 |
| Issue: | iss. 11 |
| Start page: | p. E18 |
| End page: | p. 20 |
| Annotation: | Arendrup, M C Rodriguez-Tudela, J-L Lass-Florl, C Cuenca-Estrella, M Donnelly, J P Hope, W European committee on antimicrobial susceptibility testing - subcommittee on antifungal susceptibility testing (EUCAST-AFST)* France Clin Microbiol Infect. 2011 Nov;17(11):E18-20. doi: 10.1111/j.1469-0691.2011.03647.x. Epub 2011 Sep 16. |
| Abstract: | The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing has determined breakpoints for anidulafungin for Candida spp. This Technical Note is based on the EUCAST anidulafungin rationale document (available at: http://www.eucast.org). Species-specific breakpoints for C. albicans are S </=0.03 mg/L and R >0.03 mg/L and for C. glabrata, C. tropicalis and C. krusei S </=0.06 mg/L and R >0.06 mg/L. C. parapsilosis was not regarded a good target for anidulafungin. There are insufficient data to set breakpoints for other species. The breakpoints are based upon pharmacokinetic data, epidemiological cut-off values and clinical experience. Breakpoints will be reviewed regularly. |
| Subject: | N4i 2: Invasive mycoses and compromised host
ONCOL 3: Translational research |
| Organization: | UMCN Extern
Haematology |
| Appears in Collections: | Academic bibliography
|
|
Please use this identifier to cite or link to this item:
http://hdl.handle.net/2066/95833
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|
|
